These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20008652)

  • 1. Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome.
    Lippa CF; Rosso AL; Stutzbach LD; Neumann M; Lee VM; Trojanowski JQ
    Arch Neurol; 2009 Dec; 66(12):1483-8. PubMed ID: 20008652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.
    Davidson YS; Raby S; Foulds PG; Robinson A; Thompson JC; Sikkink S; Yusuf I; Amin H; DuPlessis D; Troakes C; Al-Sarraj S; Sloan C; Esiri MM; Prasher VP; Allsop D; Neary D; Pickering-Brown SM; Snowden JS; Mann DM
    Acta Neuropathol; 2011 Dec; 122(6):703-13. PubMed ID: 21968532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R
    Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
    Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
    Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43.
    Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA
    JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies.
    van Leeuwen FW; van Tijn P; Sonnemans MA; Hobo B; Mann DM; Van Broeckhoven C; Kumar-Singh S; Cras P; Leuba G; Savioz A; Maat-Schieman ML; Yamaguchi H; Kros JM; Kamphorst W; Hol EM; de Vos RA; Fischer DF
    Neurology; 2006 Jan; 66(2 Suppl 1):S86-92. PubMed ID: 16432153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease.
    Tremblay C; St-Amour I; Schneider J; Bennett DA; Calon F
    J Neuropathol Exp Neurol; 2011 Sep; 70(9):788-98. PubMed ID: 21865887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
    Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
    Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.
    Josephs KA; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Liesinger AM; Petrucelli L; Senjem ML; Ivnik RJ; Parisi JE; Petersen RC; Dickson DW
    Ann Neurol; 2015 Nov; 78(5):697-709. PubMed ID: 26224156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43 pathology in familial British dementia.
    Schwab C; Arai T; Hasegawa M; Akiyama H; Yu S; McGeer PL
    Acta Neuropathol; 2009 Aug; 118(2):303-11. PubMed ID: 19283396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.
    Amador-Ortiz C; Lin WL; Ahmed Z; Personett D; Davies P; Duara R; Graff-Radford NR; Hutton ML; Dickson DW
    Ann Neurol; 2007 May; 61(5):435-45. PubMed ID: 17469117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptic exon incorporation occurs in Alzheimer's brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43.
    Sun M; Bell W; LaClair KD; Ling JP; Han H; Kageyama Y; Pletnikova O; Troncoso JC; Wong PC; Chen LL
    Acta Neuropathol; 2017 Jun; 133(6):923-931. PubMed ID: 28332094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.
    Di Domenico F; Pupo G; Tramutola A; Giorgi A; Schininà ME; Coccia R; Head E; Butterfield DA; Perluigi M
    Free Radic Biol Med; 2014 Jun; 71():270-280. PubMed ID: 24675226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.
    Uryu K; Nakashima-Yasuda H; Forman MS; Kwong LK; Clark CM; Grossman M; Miller BL; Kretzschmar HA; Lee VM; Trojanowski JQ; Neumann M
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):555-64. PubMed ID: 18520774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease.
    Hu WT; Josephs KA; Knopman DS; Boeve BF; Dickson DW; Petersen RC; Parisi JE
    Acta Neuropathol; 2008 Aug; 116(2):215-20. PubMed ID: 18592255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients.
    Scialò C; Tran TH; Salzano G; Novi G; Caponnetto C; Chiò A; Calvo A; Canosa A; Moda F; Caroppo P; Silani V; Ticozzi N; Ratti A; Borroni B; Benussi L; Ghidoni R; Furlanis G; Manganotti P; Senigagliesi B; Parisse P; Brasselet R; Buratti E; Legname G
    Brain Commun; 2020; 2(2):fcaa142. PubMed ID: 33094285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease.
    Rohn TT
    Brain Res; 2008 Sep; 1228():189-98. PubMed ID: 18634762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.
    Josephs KA; Murray ME; Tosakulwong N; Weigand SD; Serie AM; Perkerson RB; Matchett BJ; Jack CR; Knopman DS; Petersen RC; Parisi JE; Petrucelli L; Baker M; Rademakers R; Whitwell JL; Dickson DW
    Acta Neuropathol; 2019 Feb; 137(2):227-238. PubMed ID: 30604226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.